Volume 35, Issue 29
Research Article

Objective Bayesian model selection for Cox regression

Leonhard Held

Corresponding Author

E-mail address: leonhard.held@uzh.ch

Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Hirschegraben 84, 8001 Zurich, Switzerland

Correspondence to: Leonhard Held, Department of Biostatistics, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Hirschengraben 84, 8001 Zurich, Switzerland.

E‐mail: leonhard.held@uzh.ch

Search for more papers by this author
Isaac Gravestock

Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Hirschegraben 84, 8001 Zurich, Switzerland

Search for more papers by this author
Daniel Sabanés Bové

F. Hoffmann‐La Roche Ltd, 4070 Basel, Switzerland

Search for more papers by this author
First published: 31 August 2016
Citations: 6

Abstract

There is now a large literature on objective Bayesian model selection in the linear model based on the g‐prior. The methodology has been recently extended to generalized linear models using test‐based Bayes factors. In this paper, we show that test‐based Bayes factors can also be applied to the Cox proportional hazards model. If the goal is to select a single model, then both the maximum a posteriori and the median probability model can be calculated. For clinical prediction of survival, we shrink the model‐specific log hazard ratio estimates with subsequent calculation of the Breslow estimate of the cumulative baseline hazard function. A Bayesian model average can also be employed. We illustrate the proposed methodology with the analysis of survival data on primary biliary cirrhosis patients and the development of a clinical prediction model for future cardiovascular events based on data from the Second Manifestations of ARTerial disease (SMART) cohort study. Cross‐validation is applied to compare the predictive performance with alternative model selection approaches based on Harrell's c‐Index, the calibration slope and the integrated Brier score. Finally, a novel application of Bayesian variable selection to optimal conditional prediction via landmarking is described. Copyright © 2016 John Wiley & Sons, Ltd.

Number of times cited according to CrossRef: 6

  • Validation of discrete time‐to‐event prediction models in the presence of competing risks, Biometrical Journal, 10.1002/bimj.201800293, 62, 3, (643-657), (2019).
  • Dynamic clinical prediction models for discrete time‐to‐event data with competing risks—A case study on the OUTCOMEREA database, Biometrical Journal, 10.1002/bimj.201700259, 61, 3, (514-534), (2018).
  • The quantile probability model, Computational Statistics & Data Analysis, 10.1016/j.csda.2018.08.022, (2018).
  • On p -Values and Bayes Factors , Annual Review of Statistics and Its Application, 10.1146/annurev-statistics-031017-100307, 5, 1, (393-419), (2018).
  • Mixtures of g -Priors in Generalized Linear Models , Journal of the American Statistical Association, 10.1080/01621459.2018.1469992, (0-0), (2018).
  • Integration of Multiple Genomic Data Sources in a Bayesian Cox Model for Variable Selection and Prediction, Computational and Mathematical Methods in Medicine, 10.1155/2017/7340565, 2017, (1-19), (2017).

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.